Extracellular deposition of β-amyloid upon p53-dependent neuronal cell death in transgenic mice

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1626-1632

  LaFerla, Frank M ^a   Hall, Catherine Kappel ^a   Ngo, Lien ^a   Jay, Gilbert ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Alzheimer's disease; apoptosis; A peptide; neuritic plaques; p53

Indexed keywords

AMYLOID BETA PROTEIN; CELL NUCLEUS DNA; PROTEIN P53;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0029823454     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118957     Document Type: Article

References (36)

1. Haass, C., M.G. Schlossmacher, A.Y. Hung, C. Vigo-Pelfrey, A. Mellon, B.L. Ostaszewski, I. Lieberburg, E.H Koo, D. Schenk, D.B. Teplow, and D.J. Selkoe. 1992. Amyloid β-protein is produced by cultured cells during normal metabolism. Nature (Lond.). 359:322-325.
2. Shoji, M., T.E. Golde, J. Ghiso, T.T. Cheung, S. Estus, L.M. Shaffer, X.-D. Cai, D.M. McKay, R. Tintner, B. Frangione, and S.G. Younkin. 1992. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science (Wash. DC). 258:126-129.
3. Busciglio, J., D.H. Gabuzda, P. Matsudaira, and B.A. Yankner. 1993. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA 90:2092-2096.
4. Wertkin, A.M., R.S. Turner, S.J. Pleasure, T.E. Golde, S.G. Younkin, J.Q. Trojanowski, and V.M.-Y. Lee. 1993. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. Natl. Acad. Sci. USA. 90:9513-9517.
5. Martin, B.L., G. Schrader-Fischer, J. Busciglio, M. Duke, P. Pagenetti, and B.A. Yankner. 1995. Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J. Biol. Chem. 270: 26727-26730.
6. Yang, A.J., M. Knauer, D.A. Burdick, and C. Glabe. 1995. Intracellular Aβ 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J. Biol. Chem. 270:14786-14792.
7. Selkoe, D.J. 1995. Deciphering Alzheimer's disease: molecular genetics and cell biology yield major clues. J. NIH Res. 7:57-64.
8. Citron, M., T. Oltersdorf, C. Haass, L. McConlogue, A.Y. Hung, P. Seubert, C. Vigo-Pelfrey, I. Lieberburg, and D.J. Selkoe. 1992. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature (Lond.). 360:672-674.
9. Cai, X.-D., T.E. Golde, and S.G. Younkin. 1993. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science (Wash. DC). 259:514-516.
10. Selkoe, D.J. 1994. Normal and abnormal biology of the β-amyloid precursor protein. Anna. Rev. Neurosci. 17:489-517.
11. LaFerla, F.M., B.T Tinkle, C.J. Bieberich, C. Haudenschild, and G. Jay. 1995. The Alzheimer's Aβ peptide induces neurodegeneration and apoptosis in transgenic mice. Nat. Genet. 9:21-30.
12. Ueda, H., S.J. Ullrich, J.D. Gangemi, C.A. Kappel, L. Ngo, M.A. Feitelson, and G. Jay. 1995. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet. 9:41-47.
13. Guntern, R., C. Bouras, P.R. Hof, and P.G. Vallet. 1992. An improved thioflavin S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia. (Basel). 48:8-10.
14. Gavrielli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
15. Majno, G., and I. Joris. 1995. Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol. 146:3-15.
16. Korsmeyer, S.J. 1995. Regulators of cell death. Trends Genet. 11:101-105.
17. Hockenbery, D. 1995. Defining apoptosis. Am. J. Pathol. 146:16-19.
18. Oren, M. 1994. Relationship of p53 to the control of apoptotic cell death. Semin. Cancer Biol. 5:221-227.
19. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.). 362:847-849.
20. Clark, A.R., CA. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.). 362:849-852.
21. Li, Y., M. Chopp, Z. Zhang, C. Zaloga, L. Niewenhuis, and S. Gautam. 1994. p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke. 25:849-856.
22. Sakhi, S., A. Bruce, N. Sun, G. Tocc,. M. Baudry, and S.S. Schreiber. 1994. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA. 91:7525-7529.
23. Shearman, M.S., C.I. Ragan, and L.L. Iversen. 1994. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1470-1474.
24. Hensley, K., J.M. Carney, M.P. Mattson, M. Aksenova, M. Harris, J.F. Wu, R.A. Floyd, and D.A. Butterfield. 1994. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:3270-3274.
25. Behl, C., J.B. Davis, R. Lesley, and D. Schubert. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:817-827.
26. Tishler, R.B., S.K. Calderwood, C.N. Coleman, and B.D. Price. 1993. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53:2212-2216.
27. Kim, K.S., D.L. Miller, V.J. Sapienza, C.J. Chen, C. Bai, I. Grundke-Iqbal, J.R. Currie, and H.M. Wisniewski. 1988. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Comm. 2:121-130.
28. Price, D.L., and S.S. Sisodia. 1994. Cellular and molecular biology of Alzheimer's disease and animal models. Annu. Rev. Med. 45:435-446.
29. Masliah, E., R.D. Terry, M. Alford, R. DeTeresa, and L.A. Hansen. 1991. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am. J. Pathol. 138:235-246.
30. Games, D., D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, F. Gillespie et al. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717Fβ-amyloid precursor protein. Nature (Lond.). 373:523-527.
31. Sasahara, M., J.W.U. Fries, E.W. Raines, A.M. Gown, L.E. Westrum, M.P. Frosch, DT. Bonthron, R. Ross, and T. Collins. 1991. PDGF-B chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell. 64:217-227.
32. Martin, L.J., CA. Pardo, L.C. Cork, and D.L. Price. 1994. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145: 1358-1381.
33. Perry, G., P. Cras, S.L. Siedlak, M. Tabaton, and M. Kawai. 1992. β-protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 140:283-290.
34. Murphy, G.M., L.S. Forno, L. Higgins, J.M. Scardina, L.F. Eng, and B. Cordell. 1994. Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am. J. Pathol. 144:1082-1088.
35. Yoskikawa, K., T. Aizawa, and Y. Hayashi. 1992. Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature (Lond.). 359:64-67.
36. Fukuchi, K., K. Kamino, S.S. Deeb, A.C. Smith, T. Dang, and G.M. Martin. 1992. Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity. Biochem. Biophys. Res. Commun. 182:165-173.